| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Italy | 7 | |
| #2 | Germany | 6 | |
| #3 | Spain | 6 | |
| #4 | Japan | 6 | |
| #5 | Netherlands | 6 | |
| #6 | Austria | 5 | |
| #7 | Belgium | 5 | |
| #8 | Canada | 4 | |
| #9 | Finland | 4 | |
| #10 | Hungary | 4 | |
| #11 | African Intellectual Property Organization | 4 | |
| #12 | Portugal | 4 | |
| #13 | Sweden | 4 | |
| #14 | Australia | 3 | |
| #15 | France | 3 | |
| #16 | United States | 3 | |
| #17 | Denmark | 2 | |
| #18 | Norway | 2 | |
| #19 | USSR (Union of Socialist Soviet Republics) | 2 | |
| #20 | Argentina | 1 | |
| #21 | Switzerland | 1 | |
| #22 | German Democratic Republic | 1 | |
| #23 | Egypt | 1 | |
| #24 | EPO (European Patent Office) | 1 | |
| #25 | Greece | 1 | |
| #26 | Ireland | 1 | |
| #27 | India | 1 | |
| #28 | Poland | 1 | |
| #29 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Acyclic or carbocyclic compounds | |
| #4 | Medical preparations | |
| #5 | Unspecified technologies | |
| #6 | Sugars |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vegezzi Davide | 14 |
| #2 | Mora Enrico Corvi | 9 |
| #3 | Vegezzi D | 6 |
| #4 | Enriko Korubui Mora | 3 |
| #5 | Dabide Begetsutsui | 3 |
| #6 | Mora Enriko Korvi | 2 |
| #7 | Corvi Mora E | 1 |
| #8 | Vegezzi Devid | 1 |
| #9 | Enrico Corvi Mora | 1 |
| #10 | Corvi Mora Enrico | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA1129885A | Method for the preparation of verbenone, myrtenal and pinocarveol and their therapeutical use | |
| JPS5661376A | Manufacture of lysergol derivative | |
| JPS55111484A | Novel derivative of eburnamonine | |
| PT69205A | Novel derivatives of eburnamonina and related method of manufacturing | |
| ES476725A1 | A process for preparing lysergol derivatives. | |
| DE2833967A1 | METHOD FOR PRODUCING APOVINCAMINE | |
| PT66201A | Method and composition for the therapeutics of brain circulatory diseases |